Bullfrog AI Holdings, Inc. Common Stock (BFRG) is a Healthcare · Health Information Services company listed on NASDAQ. Price $0.46 (-0.90%), Market cap $0.02B, 52-week low–high $0.46 ~ $2.10.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic
Financial statements, price targets, institutional (13F) holdings and related news for Bullfrog AI Holdings, Inc. Common Stock are updated in real time on BlackAll Trade.
Bullfrog AI Holdings, Inc. Common Stock trades at $0.46 (-0.90%). Real-time quotes and charts are available on BlackAll Trade.
Bullfrog AI Holdings, Inc. Common Stock has a market cap of about $0.02B.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare